Providing genetic risk information to parents of newborns with sickle cell trait: Role of the general practitioner in neonatal screening

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 10, 2011, Pages 671-675

  Vansenne, Fleur ^a   De Borgie, Corianne A J M ^a   Legdeur, Monica ^a   Spauwen, Marjo Oey ^b   Peters, Marjolein ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE CARRIER; FEMALE; GENERAL PRACTITIONER; GENETIC RISK; GENETIC TRAIT; HEALTH PROGRAM; HEMOGLOBINOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEONATAL SCREENING PROGRAM; NEWBORN SCREENING; PARENT COUNSELING; PATIENT COUNSELING; QUESTIONNAIRE; SICKLE CELL ANEMIA; WORK EXPERIENCE;

ADULT; AGED; FEMALE; GENERAL PRACTITIONERS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; NEONATAL SCREENING; PARENTS; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S ROLE; QUESTIONNAIRES; RISK; SICKLE CELL TRAIT;

EID: 80054696454     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0232     Document Type: Article

References (23)

1. Ahmed S, Atkin K, Hewison J, Green J (2006) The influence of faith and religion and the role of religious and community leaders in prenatal decisions for sickle cell disorders and thalassaemia major. Prenat Diagn 26:801-809. (Pubitemid 44519653)
2. Almeida AM, Henthorn JS, Davies SC (2001) Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region. Br J Haematol 112:32-35. (Pubitemid 32151145)
3. Baars MJ, Henneman L, Ten Kate LP (2005) Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists and pediatricians: a global problem. Genet Med 7:605-610. (Pubitemid 41753011)
4. Bolhuis PA, Page-Christiaens GC (2005) The advisory report "Neonatal screening" from the Health Council of the Netherlands. Ned Tijdschr Geneeskd 149:2857-2860.
5. De Montalembert M, Bonnet D, Lena-Russo D, Briard ML (2005) Ethical aspects of neonatal screening for sickle cell disease in Western European countries. Acta Paediatr 94:528-530. (Pubitemid 40646672)
6. Emery J, Watson E, Rose P, Andermann A (1999) A systematic review of the literature: exploring the role of primary care in genetic services. Fam Pract 16:426-445. (Pubitemid 29410766)
7. Gaston MH, Verter JI, Woods G, et al. (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Eng J Med 314:1593-1599. (Pubitemid 16118215)
8. Giordano PC, Bouva MJ, Harteveld CL (2004) A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a prevention strategy in the Netherlands. Hemoglobin 28:287-296.
9. Giordano PC, Dihal AA, Harteveld CL (2005) Estimating the attitude of immigrants toward primary prevention of the he-moglobinopathies. Prenat Diagn 25:885-893. (Pubitemid 41508870)
10. Gulbis B, Cotton F, Ferster A, et al. (2009) Neonatal haemoglo-binopathy screening in Belgium. J Clin Pathol 62:39-41.
11. Hayeems RZ, Miller FA, Little J, et al. (2009) Informing parents about expanded newborn screening: influences on provider involvement. Pediatrics 124:950-958.
12. Heijboer H, Van den Tweel XW, Peters M, et al. (2001) One year of neonatal screening in the Emma Kinderziekenhuis/Academic Medical Center in Amsterdam. Ned Tijdschr Gen-eeskd 145:1795-1799. (Pubitemid 32851641)
13. Kemper AR, Uren RL, Moseley KL, Clark SJ (2006) Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results. Pediatrics 118: 1836-1841. (Pubitemid 46393663)
14. Kerruish NJ, Webster D, Dickson N (2008) Information and consent for newborn screening: practices and attitudes of service providers. J Med Ethics 34:648-652.
15. Laird L, Dezateaux C, Anionwu EN (1996) Neonatal screening for sickle cell disorders: what about the carrier infants? BMJ 17:407-411. (Pubitemid 26289982)
16. National Institute for Public Health and the Environment, Centre for Population Screening. (2008) Evaluation of the neonatal newborn screening in children born in 2008. Leiden. February 2010, ISBN no: 978-90-5986-3040-8.
17. Parker H, Qureshi N, Ulph F, Kai J (2007) Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges. BMC Health Serv Res 7:203.
18. Peters M, Appel IM, Cnossen MH, et al. (2009) Sickle cell disease in heel injection screening I. Ned Tijdschr Geneesk 153:854-857.
19. Rebolj M, Van Ballegooijen M, Berkers LM, Habbema D (2007) Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 120:806-812. (Pubitemid 46175400)
20. Schouten BC, Meeuwesen L, Harmsen HAM (2009) GPs' interactional styles in consultations with Dutch and ethnic minority patients. J Immigr Minor Health 11:468-475.
21. Suther S, Goodson P (2003) Barriers to provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med 5:70-76. (Pubitemid 36992615)
22. Vansenne F, de Borgie CA, Bouva MJ, et al. (2009) Sickle cell disease in heel injection screening II. Ned Tijdschr Geneeskd 153:858-861.
23. Vichinsky E, Hurst D, Earles A, et al. (1988) Newborn screening for sickle cell disease: effect on mortality. Pediatrics 81:749-755.